Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
2016-2020 Tuberculosis Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment-France, Germany, Italy, Japan, Spain, UK, USA-Hospitals, Commercial and Public Health Labs, POC Locations
US$ 760.00
This report presents test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Tuberculosis tests performed in the following market segments:
March 2016
2016-2020 Yersinia Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment-France, Germany, Italy, Japan, Spain, UK, USA-Hospitals, Commercial and Public Health Labs, POC Locations
US$ 480.00
This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Yersinia tests performed in the following market segments:
March 2016
Aesculap: 2016 Strategies, Marketing, R&D, Technologies, Products, Organization
US$ 1,480.00
... assessment of Aesculap, one of the world’s leading orthopedics companies, provides significant competitor ... implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global orthopedics market.
March 2016
22 pages
